Reinventing GPCR drug discovery using systems biology and Artificial Intelligence

We integrate experimental and computational pharmacology to reveal critical properties of novel GPCR drug candidates.

The InterAx Platform

Compounds
Compounds

Compounds

Arrow left to right
Arrow left to right
Assays

The InterAx Platform

Assays

Time-resolved cellular assays

Arrow double
Arrow double
Systems biology analysis
Systems biology analysis

Systems biology analysis

Arrow split
Arrow split
Clustered Compounds
Clustered Compounds

Clustering

Arrow merge
Arrow merge
In vivo
In vivo

Better prediction of in vivo effects

Compounds

Time-resolved cellular assays

Systems biology analysis

Clustering

Better prediction of in vivo effects

InterAx helps partners to accelerate and optimize hit‑to‑lead identification for GPCRs.

With Support From

Featured News

APR 2020

APR 2020

A Spanish-Swiss Liaison to fight COVID-19
APR 2020

APR 2020

InterAx Biotech supporting the COVID-19 initiative SARS-CoV-2/ACE-2 pseudovirus entry blocking assay
DEC 2019

DEC 2019

InterAx Biotech and GPCR Therapeutics Inc collaborate for the identification of compounds with superior biological properties targeting GPCR heteromers

Meeting Opportunities

No event found!